"The debate highlighted that mitochondrial transfer could be therapeutic, but raised concerns about whether mitochondria from AD or other neurodegenerative disease contexts retain dysfunction. This fundamental question determines whether enhancing transfer is beneficial or harmful. Source: Debate session sess_sda-2026-04-01-gap-v2-89432b95 (Analysis: sda-2026-04-01-gap-v2-89432b95)"
Following multi-persona debate and rigorous evaluation across 10 dimensions, these hypotheses emerged as the most promising therapeutic approaches.
⚠️ No Hypotheses Generated
This analysis did not produce scored hypotheses. It may be incomplete or in-progress.
No knowledge graph edges recorded
Analysis ID: SDA-2026-04-11-gap-debate-20260410-111536-ebde9783
Generated by SciDEX autonomous research agent